Your browser doesn't support javascript.
loading
Automated identification of cell populations in flow cytometry data with transformers.
Wödlinger, Matthias; Reiter, Michael; Weijler, Lisa; Maurer-Granofszky, Margarita; Schumich, Angela; Sajaroff, Elisa O; Groeneveld-Krentz, Stefanie; Rossi, Jorge G; Karawajew, Leonid; Ratei, Richard; Dworzak, Michael N.
Afiliação
  • Wödlinger M; TU Wien, Vienna, Austria; St Anna Children's Cancer Research Institute, Vienna, Austria. Electronic address: mwoedlinger@cvl.tuwien.ac.at.
  • Reiter M; TU Wien, Vienna, Austria; St Anna Children's Cancer Research Institute, Vienna, Austria.
  • Weijler L; TU Wien, Vienna, Austria.
  • Maurer-Granofszky M; St Anna Children's Cancer Research Institute, Vienna, Austria; Labdia Labordiagnostik GmbH.
  • Schumich A; St Anna Children's Cancer Research Institute, Vienna, Austria; Labdia Labordiagnostik GmbH.
  • Sajaroff EO; Cellular Immunology Laboratory, Hospital de Pediatria "Dr. Juan P. Garrahan", Buenos Aires, Argentina.
  • Groeneveld-Krentz S; Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Rossi JG; Cellular Immunology Laboratory, Hospital de Pediatria "Dr. Juan P. Garrahan", Buenos Aires, Argentina.
  • Karawajew L; Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Ratei R; Department of Hematology, Oncology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
  • Dworzak MN; St Anna Children's Cancer Research Institute, Vienna, Austria.
Comput Biol Med ; 144: 105314, 2022 05.
Article em En | MEDLINE | ID: mdl-35247762
ABSTRACT
Acute Lymphoblastic Leukemia (ALL) is the most frequent hematologic malignancy in children and adolescents. A strong prognostic factor in ALL is given by the Minimal Residual Disease (MRD), which is a measure for the number of leukemic cells persistent in a patient. Manual MRD assessment from Multiparameter Flow Cytometry (FCM) data after treatment is time-consuming and subjective. In this work, we present an automated method to compute the MRD value directly from FCM data. We present a novel neural network approach based on the transformer architecture that learns to directly identify blast cells in a sample. We train our method in a supervised manner and evaluate it on publicly available ALL FCM data from three different clinical centers. Our method reaches a median F1 score of ≈0.94 when evaluated on 519 B-ALL samples and shows better results than existing methods on 4 different datasets.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article